Omega-3 Fatty Acids (EPA/DHA) için Chronic Inflammation

References

1. [1] Mahmut Bodur et al.. Mol Nutr Food Res. 2025. Immunomodulatory Effects of Omega-3 Fatty Acids: Mechanistic Insights and Health Implications. doi:10.1002/mnfr.202400752 PubMed
2. [2] Vicente Javier Clemente-Suárez et al.. Nutrients. 2025. Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review. doi:10.3390/nu17050884 PubMed
3. [3] Charles N Serhan et al.. Annu Rev Physiol. 2025. Proresolving Lipid Mediators in the Respiratory System. doi:10.1146/annurev-physiol-020924-033209 PubMed
4. [4] Marta Vomero et al.. Autoimmun Rev. 2025. Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives. doi:10.1016/j.autrev.2025.103896 PubMed
5. [5] Joanna Polom et al.. Nutrients. 2025. Employing Nutrition to Delay Aging: A Plant-Based Telomere-Friendly Dietary Revolution. doi:10.3390/nu17122004 PubMed
6. [6] Ludmila Müller et al.. Front Immunol. 2025. Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle. doi:10.3389/fimmu.2025.1708280 PubMed
7. [7] Stefania Lamon-Fava. Prostaglandins Other Lipid Mediat. 2025. Associations between omega-3 fatty acid-derived lipid mediators and markers of inflammation in older subjects with low-grade chronic inflammation. doi:10.1016/j.prostaglandins.2025.106948 PubMed
8. [8] Hao Lin et al.. Lipids Health Dis. 2025. Association of omega-3, omega-6 fatty acids intakes and omega-6: omega-3 ratio with the prevalence of suicidal ideation: mediating role of … doi:10.1186/s12944-025-02587-6 PubMed
9. [9] Larissa Parreira Araújo et al.. Int J Mol Sci. 2025. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. doi:10.3390/ijms262412147 PubMed
10. [10] Sanaz Jamshidi et al.. Nutrients. 2025. The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in Peripheral Artery Disease (PAD) Patients. doi:10.3390/nu17142303 PubMed
11. [11] Jacques D Barth. Atherosclerosis. 2025. The omega effect: Harnessing fish oil for health. doi:10.1016/j.atherosclerosis.2025.120461 PubMed
12. [12] Luigi Barrea et al.. Curr Obes Rep. 2025. Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), … doi:10.1007/s13679-025-00630-2 PubMed
13. [13] Khursheed Muzammil et al.. Prostaglandins Other Lipid Mediat. 2024. The effects of ω-3 fatty acids on inflammatory and oxidative stress markers in patients with Type 2 diabetes mellitus: A … doi:10.1016/j.prostaglandins.2024.106887 PubMed
14. [14] Jisun So et al.. Prostaglandins Leukot Essent Fatty Acids. 2024. Sex differences in lipid mediators derived from omega-3 fatty acids in older individuals with low-grade chronic inflammation. doi:10.1016/j.plefa.2024.102655 PubMed
15. [15] E M Arshad Ali et al.. J Pharm Bioallied Sci. 2024. Effect of Omega-3 Fatty Acid Supplementation on Periodontal Inflammation and Pocket Depth Reduction. doi:10.4103/jpbs.jpbs_1173_24 PubMed
16. [16] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
17. [17] R Poggioli et al.. Eur Rev Med Pharmacol Sci. 2023. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in … doi:10.26355/eurrev_202308_33310 PubMed
18. [18] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
19. [19] Charles N Serhan et al.. Cancer Metastasis Rev. 2023. Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next Pandemic? doi:10.1007/s10555-023-10091-5 PubMed
20. [20] Jane Pei-Chen Chang et al.. Brain Behav Immun. 2023. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized … doi:10.1016/j.bbi.2023.06.008 PubMed
21. [21] Angélica Borja-Magno et al.. Front Nutr. 2023. Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid … doi:10.3389/fnut.2023.1156995 PubMed
22. [22] Zhanwei Zhang et al.. Int Immunopharmacol. 2023. Maresin1: A multifunctional regulator in inflammatory bone diseases. doi:10.1016/j.intimp.2023.110308 PubMed
23. [23] Yanbin Dong et al.. Nutrients. 2022. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL … doi:10.3390/nu14245307 PubMed
24. [24] Jeneen Panezai et al.. Toxicol Appl Pharmacol. 2022. Resolution of inflammation: Intervention strategies and future applications. doi:10.1016/j.taap.2022.116089 PubMed
25. [25] Sawan Ali et al.. Biomol Concepts. 2022. Effect of omega-3 fatty acids on the telomere length: A mini meta-analysis of clinical trials. doi:10.1515/bmc-2021-0024 PubMed
26. [26] Anthony D Pisaniello et al.. Am J Cardiol. 2022. Association Between Omega-3 Fatty Acid Levels and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis). doi:10.1016/j.amjcard.2022.08.026 PubMed
27. [27] Ellen C Keeley et al.. Am Heart J Plus. 2022. Coronary microvascular dysfunction as a chronic inflammatory state: Is there a role for omega-3 fatty acid treatment? doi:10.1016/j.ahjo.2022.100098 PubMed
28. [28] Anandita Pal et al.. Nutrients. 2020. Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other? doi:10.3390/nu12123718 PubMed
29. [29] Fumitoshi Koga et al.. Reprod Med Biol. 2020. Relationship between nutrition and reproduction. doi:10.1002/rmb2.12332 PubMed
30. [30] Kylie A Abbott et al.. Clin Nutr. 2020. Association between plasma phospholipid omega-3 polyunsaturated fatty acids and type 2 diabetes is sex dependent: The Hunter Community Study. doi:10.1016/j.clnu.2019.04.007 PubMed
31. [31] Mohita Sharma et al.. Toxicol Mech Methods. 2019. Redox modulatory protective effects of ω-3 fatty acids rich fish oil against experimental colitis. doi:10.1080/15376516.2018.1553220 PubMed
32. [32] Mahdi Sepidarkish et al.. Diabetes Metab Syndr. 2019. Effect of omega-3 fatty acid plus vitamin E Co-Supplementation on lipid profile: A systematic review and meta-analysis. doi:10.1016/j.dsx.2019.03.018 PubMed
33. [33] Kenneth Yong et al.. J Ren Nutr. 2019. The Effects of OMEGA-3 Fatty Acid Supplementation Upon Interleukin-12 and Interleukin-18 in Chronic Kidney Disease Patients. doi:10.1053/j.jrn.2019.01.001 PubMed
34. [34] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
35. [35] Robert A Whittington et al.. Front Immunol. 2017. Impaired Resolution of Inflammation in Alzheimer's Disease: A Review. doi:10.3389/fimmu.2017.01464 PubMed
36. [36] Tim Y Hou et al.. Eur J Pharmacol. 2016. Omega-3 fatty acids, lipid rafts, and T cell signaling. doi:10.1016/j.ejphar.2015.03.091 PubMed
37. [37] K Kaliannan et al.. Int J Obes (Lond). 2016. Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity. doi:10.1038/ijo.2016.27 PubMed
38. [38] Evan Atlantis et al.. Int J Evid Based Healthc. 2016. The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive … doi:10.1097/XEB.0000000000000056 PubMed
39. [39] Giacomo Garibotto et al.. Clin J Am Soc Nephrol. 2016. Studying Muscle Protein Turnover in CKD. doi:10.2215/CJN.04790516 PubMed
40. [40] Jun Miyata et al.. Allergol Int. 2015. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. doi:10.1016/j.alit.2014.08.003 PubMed
41. [41] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed
42. [42] Ahmed A Daak et al.. Blood Cells Mol Dis. 2015. Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-κB) gene and blood cell adhesion molecule expression in patients with … doi:10.1016/j.bcmd.2015.03.014 PubMed
43. [43] Ann C Skulas-Ray. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. doi:10.1016/j.prostaglandins.2015.02.001 PubMed
44. [44] Milan Fiala et al.. J Alzheimers Dis. 2015. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment. doi:10.3233/JAD-150367 PubMed
45. [45] Afshin Gharekhani et al.. Eur J Clin Pharmacol. 2014. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical … doi:10.1007/s00228-014-1666-1 PubMed
46. [46] Owen J Kelly et al.. Nutr Res. 2013. Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. doi:10.1016/j.nutres.2013.04.012 PubMed
47. [47] Wardhana et al.. Acta Med Indones. 2011. The role of omega-3 fatty acids contained in olive oil on chronic inflammation. PubMed
48. [48] Linda A Linday. J Am Coll Nutr. 2010. Cod liver oil, young children, and upper respiratory tract infections. doi:10.1080/07315724.2010.10719894 PubMed
49. [49] Trevor A Mori et al.. Curr Atheroscler Rep. 2004. Omega-3 fatty acids and inflammation. doi:10.1007/s11883-004-0087-5 PubMed
50. [50] T J Jeerakathil et al.. Curr Atheroscler Rep. 2001. Prevention of strokes. doi:10.1007/s11883-001-0026-7 PubMed
51. [51] D A Troyer et al.. Age (Omaha). 1998. Effects of calorie restriction and ω-3 dietary fat on aging in short-and long-lived rodents. doi:10.1007/s11357-998-0026-4 PubMed